Thursday Program

Join us for a comprehensive full-day educational experience focused on the rapidly evolving landscape of precision allergy care. This dynamic program will explore the expanding role of biologics, small molecules, and immunotherapy across allergic and immunologic diseases, with an emphasis on practical application in clinical practice.

Through expert-led lectures, case-based discussions, and interactive panels, attendees will gain valuable insights into advanced therapeutic decision-making, patient phenotyping and endotyping, and emerging translational science. This program is designed to equip clinicians with cutting-edge strategies to optimize patient outcomes in an era of increasingly personalized care.

The Thursday Program will feature in-depth sessions led by experts in allergy, immunology, dermatology and otolaryngology.

Topics will include:

• The Era of Targeted Therapy: An overview of current and emerging biologics and small molecules, along with the role of biomarkers in guiding treatment selection.
• Phenotyping and Endotyping in Clinical Practice: Casebased discussions highlighting precision treatment approaches in asthma, atopic dermatitis, chronic urticaria, and chronic rhinosinusitis with nasal polyps (CRSwNP).
• Immunotherapy in High-Risk Patients: *A luncheon panel discussion focused on real-world challenges, including risk assessment and management strategies for complex patients.
• Food Allergy Immunotherapy: Current and emerging approaches to OIT, SLIT, and EPIT, including long-term outcomes and the role of adjunctive biologics.
• Revisiting Immunotherapy in the Age of Biologics: Strategies for integrating allergen immunotherapy with biologic therapies, including combination approaches.
• Translational Science and Future Directions: Insights into mechanisms of immune tolerance, early intervention strategies, and next-generation therapies, including peptide and DNA/RNA platforms.

* Luncheon and ProCon Debate available to in-person Registrants only.